Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Magnetic resonance spectroscopy in intracranial tumours of glial origin.

Jaskólski DJ, Fortuniak J, Majos A, Gajewicz W, Papierz W, Liberski PP, Sikorska B, Stefańczyk L.

Neurol Neurochir Pol. 2013 Sep-Oct;47(5):438-49.

PMID:
24166565
2.

Differential diagnosis of intracranial meningiomas based on magnetic resonance spectroscopy.

Jaskólski DJ, Fortuniak J, Stefańczyk L, Majos A, Gajewicz W, Papierz W, Liberski PP, Sikorska B.

Neurol Neurochir Pol. 2013 May-Jun;47(3):247-55.

PMID:
23821422
3.

Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.

Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.

Acta Radiol. 2010 Apr;51(3):316-25. doi: 10.3109/02841850903482901.

PMID:
20092374
4.

Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.

Chawla S, Oleaga L, Wang S, Krejza J, Wolf RL, Woo JH, O'Rourke DM, Judy KD, Grady MS, Melhem ER, Poptani H.

J Neuroimaging. 2010 Jan;20(1):3-8. doi: 10.1111/j.1552-6569.2008.00307.x.

PMID:
19021846
5.

In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.

Likavcanová K, Dobrota D, Liptaj T, Prónayová N, Mlynárik V, Belan V, Galanda M, Béres A, De Riggo J.

Gen Physiol Biophys. 2005 Sep;24(3):327-35.

6.

Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.

Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.

Invest Radiol. 2013 May;48(5):295-301. doi: 10.1097/RLI.0b013e31827188d6.

PMID:
23296081
7.

Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.

Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH.

Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.

PMID:
20708868
8.

Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.

Zhang K, Li C, Liu Y, Li L, Ma X, Meng X, Feng D.

Neuroradiology. 2007 Nov;49(11):913-9. Epub 2007 Sep 1.

PMID:
17763847
9.

Comparison of multiple parameters obtained on 3T pulsed arterial spin-labeling, diffusion tensor imaging, and MRS and the Ki-67 labeling index in evaluating glioma grading.

Fudaba H, Shimomura T, Abe T, Matsuta H, Momii Y, Sugita K, Ooba H, Kamida T, Hikawa T, Fujiki M.

AJNR Am J Neuroradiol. 2014 Nov-Dec;35(11):2091-8. doi: 10.3174/ajnr.A4018. Epub 2014 Jul 3.

10.

Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.

Bradac O, Vrana J, Jiru F, Kramar F, Netuka D, Hrabal P, Horinek D, de Lacy P, Benes V.

Br J Neurosurg. 2014 Oct;28(5):631-6. doi: 10.3109/02688697.2013.872229. Epub 2013 Dec 30.

PMID:
24377726
11.

Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.

Ng WH, Lim T.

J Clin Neurosci. 2008 May;15(5):502-6. doi: 10.1016/j.jocn.2007.04.005. Epub 2008 Mar 10.

PMID:
18334298
12.

Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Uçöz T.

AJNR Am J Neuroradiol. 2003 Feb;24(2):225-33.

13.

Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy.

Fountas KN, Kapsalaki EZ, Vogel RL, Fezoulidis I, Robinson JS, Gotsis ED.

Stereotact Funct Neurosurg. 2004;82(2-3):90-7. Epub 2004 Mar 25.

PMID:
15305081
14.
15.

Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.

Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK.

AJNR Am J Neuroradiol. 1995 Sep;16(8):1593-603.

16.

Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.

Yerli H, Ağildere AM, Ozen O, Geyik E, Atalay B, Elhan AH.

Diagn Interv Radiol. 2007 Mar;13(1):3-9.

17.

Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain.

Kaminogo M, Ishimaru H, Morikawa M, Ochi M, Ushijima R, Tani M, Matsuo Y, Kawakubo J, Shibata S.

Neuroradiology. 2001 May;43(5):353-63.

PMID:
11396738
18.

In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.

Zou QG, Xu HB, Liu F, Guo W, Kong XC, Wu Y.

Clin Radiol. 2011 Oct;66(10):953-60. doi: 10.1016/j.crad.2011.05.001. Epub 2011 Jun 12.

PMID:
21663899
19.

3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.

Caivano R, Lotumolo A, Rabasco P, Zandolino A, D'Antuono F, Villonio A, Lancellotti MI, Macarini L, Cammarota A.

Int J Neurosci. 2013 Aug;123(8):537-43. doi: 10.3109/00207454.2013.774395. Epub 2013 Mar 11. Review.

PMID:
23390934
20.

[Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].

Zhou GF, Wang XY, Gong CG, Liu F, Wang RW.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(8):1342-4. Chinese.

Items per page

Supplemental Content

Write to the Help Desk